{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T07:49:53Z","timestamp":1787989793585,"version":"build-2784847793"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010442","name":"Universidad Nacional de C\u00f3rdoba","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100010442","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.ejpb.2016.07.012","type":"journal-article","created":{"date-parts":[[2016,7,15]],"date-time":"2016-07-15T03:29:13Z","timestamp":1468553353000},"page":"263-272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Reduced food interaction and enhanced gastrointestinal tolerability of a new system based on risedronate complexed with Eudragit E100: Mechanistic approaches from in vitro and in vivo studies"],"prefix":"10.1016","volume":"107","author":[{"given":"M.L.","family":"Guzman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.A.","family":"Soria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Laino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.H.","family":"Manzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.E.","family":"Olivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2016.07.012_b0005","author":"Gold Standard, Inc. Risedronate"},{"key":"10.1016\/j.ejpb.2016.07.012_b0010","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bone.2011.02.011","article-title":"Bisphosphonates for postmenopausal osteoporosis","volume":"49","author":"Eastell","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.ejpb.2016.07.012_b0015","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/jps.2600831218","article-title":"On the absorption of alendronate in rats","volume":"83","author":"Lin","year":"1994","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2016.07.012_b0020","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0169-409X(00)00061-2","article-title":"Administration routes and delivery systems of bisphosphonates for the treatment of bone resorption","volume":"42","author":"Ezra","year":"2000","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2016.07.012_b0025","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-2265.1986.tb03254.x","article-title":"Absorption of oral diphosphonate in normal subjects","volume":"24","author":"Fogelman","year":"1986","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ejpb.2016.07.012_b0030","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1021\/j100675a012","article-title":"Polynuclear complex formation in solutions of calcium ion and ethane-1-hydroxy-1,1-diphosphonic acid. I. Complexometric and pH titrations","volume":"75","author":"Grabenstetter","year":"1971","journal-title":"Phys. Chem."},{"key":"10.1016\/j.ejpb.2016.07.012_b0035","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s00774-003-0459-x","article-title":"Clinical trial of risedronate in Japanese volunteers: a study on the effect of timing of dosing on absorption","volume":"22","author":"Ogura","year":"2004","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.ejpb.2016.07.012_b0040","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.amjmed.2005.12.019","article-title":"Improving compliance and persistence with bisphosphonate therapy for osteoporosis","volume":"119","author":"Emkey","year":"2006","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejpb.2016.07.012_b0045","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00198-002-1370-3","article-title":"Tolerability and compliance with risedronate in clinical practice","volume":"14","author":"Hamilton","year":"2003","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.ejpb.2016.07.012_b0050","first-page":"1322","article-title":"Primary amino-bisphosphonates: a new class of gastrotoxic drugs-comparison of alendronate and aspirin","volume":"92","author":"Graham","year":"1997","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.ejpb.2016.07.012_b0055","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/S0025-6196(11)61093-8","article-title":"Systematic review and meta-analysis of real-world adherence to drug therapy for osteoporosis","volume":"82","author":"Kothawala","year":"2007","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.ejpb.2016.07.012_b0060","author":"International Osteoporosis Foundation"},{"key":"10.1016\/j.ejpb.2016.07.012_b0065","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bone.2011.02.003","article-title":"Bisphosphonates in oncology","volume":"49","author":"Coleman","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.ejpb.2016.07.012_b0070","series-title":"Handbook of Pharmaceutical Excipients","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/978-3-540-79842-2","article-title":"Polymethacrylates","author":"Chang","year":"2009"},{"key":"10.1016\/j.ejpb.2016.07.012_b0075","doi-asserted-by":"crossref","first-page":"E54","DOI":"10.1208\/pt0802034","article-title":"Eudragit E as excipient for production of granules and tablets from Phyllanthus niruri L spray-dried extract","volume":"8","author":"Pereira de Souza","year":"2007","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2016.07.012_b0080","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0378-5173(02)00622-1","article-title":"Design of pH-independent controlled release matrix tablets for acidic drugs","volume":"252","author":"Raob","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.07.012_b0085","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3109\/10717544.2010.520350","article-title":"Development of drug-in-adhesive transdermal patch for \u03b1-asarone and in vivo pharmacokinetics and efficacy evaluation","volume":"18","author":"Hu","year":"2011","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejpb.2016.07.012_b0090","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s11094-011-0618-7","article-title":"Interpolymer combinations of chemically complementary grades of Eudragit copolymers: a new direction in the design of peroral solid dosage forms of drug delivery systems with controlled release","volume":"45","author":"Mustafin","year":"2011","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.ejpb.2016.07.012_b0095","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1021\/mp300282f","article-title":"Eudragit E100 as a drug carrier: the remarkable affinity of phosphate ester for dimethylamine","volume":"9","author":"Guzman","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2016.07.012_b0100","unstructured":"Farmacopea Argentina, Ministerio de Salud de la Naci\u00f3n, Secretar\u00eda de Pol\u00edticas, Regulaci\u00f3n e Institutos. Administraci\u00f3n Nacional de Medicamentos, Alimentos y Tecnolog\u00eda M\u00e9dica, seventh ed., Capital Federal, Buenos Aires, Argentina, 2013 (Spanish)."},{"key":"10.1016\/j.ejpb.2016.07.012_b0105","series-title":"The National Formulary and Dispensing Information (USP 37-NF 32)","author":"United States Pharmacopoeia","year":"2014"},{"key":"10.1016\/j.ejpb.2016.07.012_b0110","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0378-5173(02)00333-2","article-title":"Release kinetics and up-take studies of model fluoroquinolones from carbomer hydrogels","volume":"246","author":"Vilches","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.07.012_b0115","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0378-5173(02)00525-2","article-title":"Equilibrium properties and mechanism of kinetic release of metoclopramide from carbomer hydrogels","volume":"250","author":"Jimenez-Kairuz","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.07.012_b0120","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejps.2007.10.002","article-title":"Interaction between a cationic polymethacrylate (Eudragit E100) and anionic drugs","volume":"33","author":"Quinteros","year":"2008","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2016.07.012_b0125","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.aca.2006.01.077","article-title":"Determination of risedronate in rat plasma samples by ion-pair high-performance liquid chromatography with UV detector","volume":"562","author":"Hui-Juan","year":"2006","journal-title":"Anal. Chem. Acta"},{"key":"10.1016\/j.ejpb.2016.07.012_b0130","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/8756-3282(95)00445-9","article-title":"Bisphosphonates: a review of their pharmacokinetic properties","volume":"18","author":"Lin","year":"1996","journal-title":"Bone"},{"key":"10.1016\/j.ejpb.2016.07.012_b0135","author":"U.S. Department of Health and Human Services Food and Drug Administration; Center for Drug Evaluation and Research (CDER); Center for Veterinary Medicine (CVM)"},{"key":"10.1016\/j.ejpb.2016.07.012_b0140","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1023\/A:1018849415297","article-title":"Nonclinical model for assessing gastric effects of bisphosphonates","volume":"42","author":"Blank","year":"1997","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.ejpb.2016.07.012_b0145","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1046\/j.1365-2036.2000.00816.x","article-title":"Gastric damage in the rat with nitrogen-containing bisphosphonates depends on pH","volume":"14","author":"Blank","year":"2000","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.ejpb.2016.07.012_b0150","first-page":"338","article-title":"Thermodynamic dissociation constants of risedronate using spectrophotometric and potentiometric pH-titration","volume":"10","author":"Meloun","year":"2012","journal-title":"Cent. Eur. J. Chem."},{"key":"10.1016\/j.ejpb.2016.07.012_b0155","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0169-409X(01)00203-4","article-title":"Environment-sensitive hydrogels for drug delivery","volume":"53","author":"Qiu","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2016.07.012_b0160","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejpb.2010.03.011","article-title":"Transdermal iontophoresis of dexamethasone sodium phosphate in vitro and in vivo: effect of experimental parameters and skin type on drug stability and transport kinetics","volume":"75","author":"C\u00e1zares-Delgadillo","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2016.07.012_b0165","doi-asserted-by":"crossref","first-page":"4058","DOI":"10.1073\/pnas.1118215109","article-title":"Lipophilic analogs of zoledronate and risedronate inhibit Plasmodium geranylgeranyl diphosphate synthase (GGPPS) and exhibit potent antimalarial activity","volume":"109","author":"Noa","year":"2011","journal-title":"PNAS"},{"key":"10.1016\/j.ejpb.2016.07.012_b0170","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1359\/jbmr.1997.12.1.66","article-title":"Pooling of clodronate urinary excretion data: a new pharmacokinetic method to study drugs with highly variable gastrointestinal absorption","volume":"12","author":"Kortekangas","year":"1997","journal-title":"J. Bone Min. Res."},{"key":"10.1016\/j.ejpb.2016.07.012_b0175","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2147\/TCRM.S52291","article-title":"Eliminating the need for fasting with oral administration of bisphosphonates","volume":"9","author":"Pazianas","year":"2013","journal-title":"Ther. Clin. Risk Manage."},{"key":"10.1016\/j.ejpb.2016.07.012_b0180","unstructured":"Product monograph, Atelvia\u00ae, Manufactured by Norwich Pharmaceuticals, Inc., marketed by: Warner Chilcott (US), LLC. U.S. Patent Nos. 5,583,122; 5,622,721; 7,645,459 B2 and 7,645,460 B2."},{"key":"10.1016\/j.ejpb.2016.07.012_b0185","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.2042-7158.2010.01229.x","article-title":"Positively-charged microemulsion for improving the oral bioavailability of alendronate: in-vitro and in-vivo assessment","volume":"63","author":"Meng","year":"2011","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2016.07.012_b0190","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3109\/10611861003667599","article-title":"Alendronate-loaded microparticles for improvement of intestinal cellular absorption","volume":"19","author":"Baek","year":"2011","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ejpb.2016.07.012_b0195","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/BF02556218","article-title":"Sodium EDTA, enhances intestinal absorption of two bisphosphonates","volume":"49","author":"Janner","year":"1991","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.ejpb.2016.07.012_b0200","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ejps.2010.06.020","article-title":"Particulate adducts based on sodium risedronate and titanium dioxide for the bioavailability enhancement of oral administered bisphosphonates","volume":"41","author":"Dissette","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2016.07.012_b0205","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1023\/A:1005574009856","article-title":"Effect of bisphosphonates on surface hydrophobicity and phosphatidylcholine concentration of rodent gastric mucosa","volume":"45","author":"Lichtenberger","year":"2000","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.ejpb.2016.07.012_b0210","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0024-3205(97)01040-0","article-title":"Alendronate induces gastric injury and delays ulcer healing in rodents","volume":"62","author":"Elliott","year":"1998","journal-title":"Life Sci."},{"key":"10.1016\/j.ejpb.2016.07.012_b0215","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1359\/jbmr.1999.14.5.784","article-title":"The effects of nitrogen-containing bisphosphonates on human epithelial (Caco-2) cells, an in vitro model for intestinal epithelium","volume":"14","author":"Twiss","year":"1999","journal-title":"J. Bone Miner. Res."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641116302946?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641116302946?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T14:56:35Z","timestamp":1536591395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641116302946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":43,"alternative-id":["S0939641116302946"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2016.07.012","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced food interaction and enhanced gastrointestinal tolerability of a new system based on risedronate complexed with Eudragit E100: Mechanistic approaches from in vitro and in vivo studies","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2016.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}